Setting the record straight on social media baseless rumour.

Contrary to the unsubstantiated rumour making rounds on social media that some antimalarial products were banned in Europe because they cause kidney failure or damage. The drugs are not known to cause that and they are ORAL MONOTHERAPIES which ARE NOT the recommended medicines for treatment of UNCOMPLICATED MALARIA in Nigeria and many other countries just because WHO and the ministry of health here have moved beyond single or monotherapy to combination therapy for better treatment and management of malaria .

The recommended combination medicines for malaria in Nigeria are Artesunate + Amodiaquine (AA), Artemether + Lumefantrinr (AL) e.g Lonart and Sulphadoxine Pyrimethamine (SP), which are also the WHO recommended combinations.

The European Medicines Agency’s website was searched and it was established that:
* Artesunate is used in combination with Amodiaquine.

*Artemether is used in combination with Lumefantrine.

*Pyrimethamine is used in combination with Sulphadoxine.

*Proguanil is used in combination with other active pharmaceutical ingredient in Atovaquone.

* Halofantrine is recommended by WHO for use in area where multiple drug resistance Plasmodium falciparum malaria is prevalent.

The claim of Itodje Okiemute Godstime and any other person in respect of poisoning and kidney failure has no clinical or scientific backing.

Taking a deep, clear and good look at the mischievous write up you will see that he is talking of mono therapies , a state which Nigeria has already passed.

In actual fact, all those monotherapies are currently being used in combination with each other or other antimalarials not listed amongst them to give proper coverage and cure of the malaria not because they are harmful but because of the power of synergy to combat malaria .

We only wonder Why should anybody circulate very old information in a malicious manner ? What is the purpose? Why mention brand names and not just the generic names unless there is more to it?

It is even surprising to see scientists join in the spread of such beer parlour gist without questioning it or asking for a verifiable source of the information . We as scientists must think scientifically and PHARMACEUTICALLY. We are above such beer parlour discussions


* Guidelines for the treatment of Malaria, 3rd Edition, Geneva, World Health Organization, 2015.

* Pharmacology of Antimalarial drugs – Guidelines for treatment of Malaria – NCBI Bookshelf https//

* Nigeria National Antimalarial Treatment Policy, February, 2005.

* https//www.ema.europa/ema/index.jsp?curl-pages/me

Greenlife pharmaceuticals limited

8 replies
  1. work legal advice
    work legal advice says:

    Hello! I’ve been following your web site for a long time now and finally got the bravery to go ahead and give you a shout out from Porter Texas! Just wanted to tell you keep up the excellent work!

  2. higher education
    higher education says:

    I’m not sure where you’re getting your information, but good topic. I needs to spend some time learning more or understanding more. Thanks for magnificent info I was looking for this info for my mission.

  3. college education
    college education says:

    I’m not sure why but this blog is loading very slow for me. Is anyone else having this issue or is it a problem on my end? I’ll check back later on and see if the problem still exists.

  4. mental health
    mental health says:

    Wow, awesome blog layout! How lengthy have you been blogging for? you make running a blog glance easy. The whole glance of your web site is excellent, let alone the content!

  5. online education
    online education says:

    Good day I am so excited I found your blog page, I really found you by accident, while I was searching on Aol for something else, Anyways I am here now and would just like to say thanks for a marvelous post and a all round interesting blog (I also love the theme/design), I don’t have time to browse it all at the moment but I have bookmarked it and also added in your RSS feeds, so when I have time I will be back to read much more, Please do keep up the great work.


Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *